Autopsy report · NCT01947699
Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide
Cause of deathStaffing, sites or logistics
“PI decided to withdrawal study before recruitment started”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- University of Pittsburgh
- Sponsor type
- University, hospital or other
- Conditions
- Gestational Diabetes
- Interventions
- Glyburide; Continuous glucose monitor
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Affective Processing in Depression and Epilepsy
“PI wanted to discontinue study.” - HIV-1 Vaccine Test in Uninfected Adult Volunteers
“The study product was revised. PI withdrew the study without enrolling participants..” - Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
“PI decided to stop the study” - Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period
“No recruitment occurred and the PI stopped the study” - Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study
“Study was terminated due to PI leaving the institution”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.